↓ Skip to main content

Treatment Resistance in Severe Asthma Patients With a Combination of High Fraction of Exhaled Nitric Oxide and Low Blood Eosinophil Counts

Overview of attention for article published in Frontiers in Pharmacology, April 2022
Altmetric Badge

Mentioned by

twitter
1 X user

Citations

dimensions_citation
5 Dimensions

Readers on

mendeley
11 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Treatment Resistance in Severe Asthma Patients With a Combination of High Fraction of Exhaled Nitric Oxide and Low Blood Eosinophil Counts
Published in
Frontiers in Pharmacology, April 2022
DOI 10.3389/fphar.2022.836635
Pubmed ID
Authors

Yuki Hoshino, Tomoyuki Soma, Yoshitaka Uchida, Yuki Shiko, Kazuyuki Nakagome, Makoto Nagata

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 11 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 11 100%

Demographic breakdown

Readers by professional status Count As %
Student > Postgraduate 2 18%
Student > Bachelor 1 9%
Lecturer > Senior Lecturer 1 9%
Student > Master 1 9%
Unknown 6 55%
Readers by discipline Count As %
Medicine and Dentistry 4 36%
Pharmacology, Toxicology and Pharmaceutical Science 1 9%
Computer Science 1 9%
Biochemistry, Genetics and Molecular Biology 1 9%
Unknown 4 36%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 20 April 2022.
All research outputs
#20,941,392
of 23,577,654 outputs
Outputs from Frontiers in Pharmacology
#10,871
of 17,181 outputs
Outputs of similar age
#359,749
of 442,872 outputs
Outputs of similar age from Frontiers in Pharmacology
#765
of 1,272 outputs
Altmetric has tracked 23,577,654 research outputs across all sources so far. This one is in the 1st percentile – i.e., 1% of other outputs scored the same or lower than it.
So far Altmetric has tracked 17,181 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.0. This one is in the 1st percentile – i.e., 1% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 442,872 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 1,272 others from the same source and published within six weeks on either side of this one. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.